Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.47
Delayed Data
As of 11:53am ET
 -0.04 / -2.65%
Today’s Change
0.97
Today|||52-Week Range
2.02
-22.22%
Year-to-Date

Today’s Trading

Previous close1.51
Today’s open1.51
Day’s range1.46 - 1.51
Volume70,710
Average volume (3 months)520,531
Market cap$227.0M
Dividend yield--
Data as of 11:53am ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+47.92%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV-0.13-1.38%
GALEGalena Biopharma Inc0.000.00%
ZGNXZogenix Inc-0.01-1.06%
TKAITokai Pharmaceutical...-0.08-0.74%
Data as of 12:10pm ET, 04/28/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers